Orleans Capital Management Corp LA Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Orleans Capital Management Corp LA lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,839 shares of the healthcare conglomerate's stock after selling 470 shares during the period. UnitedHealth Group makes up 2.1% of Orleans Capital Management Corp LA's holdings, making the stock its 12th biggest position. Orleans Capital Management Corp LA's holdings in UnitedHealth Group were worth $3,651,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $30,000. Promus Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth $32,000. Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at $40,000. Finally, DecisionPoint Financial LLC boosted its stake in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 2.9 %

UnitedHealth Group stock traded down $15.50 during trading on Friday, hitting $524.94. The company had a trading volume of 9,914,705 shares, compared to its average volume of 4,261,985. The stock has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's 50 day simple moving average is $509.24 and its 200-day simple moving average is $542.37. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The business's quarterly revenue was up 6.8% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is presently 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Buy" and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.